Sciatica treatment trial fizzles out after just 2 patients
NCT ID NCT06924853
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small study tested whether an injection made from a patient's own blood (platelet lysate) could reduce leg pain from sciatica better than a saltwater injection. Only 2 people took part before the study was stopped early, so we cannot draw any firm conclusions. The approach remains experimental.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- platelet lysate
- What this could lead to
- If it worked, this could point toward a treatment for sciatica using a patient's own blood components.
- What could go wrong
- The trial was terminated early with only 2 participants, so we have almost no reliable data. It is unclear if platelet lysate helps more than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
2 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Nov 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Must be 18-65 years of age, inclusive, at time of signing informed consent 2. At least moderate pain at screening using Patient Global Impression of Severity (PGIS) 3. Diagnosis of lumbosacral radiculopathy (LSR) radiating to or below the knee in a single dermatomal pattern (L4, L5, or S1) with onset of clinical symptoms less than 2 year prior to screening visit 4. Presence of one of the following: a radicular pattern (L4, L5, or S1) of sensory, reflex or strength changes 5. Presence of persistent unilateral radicular pain. Have significant leg pain, numbness, or tingling that causes the patient to alter or change activities. 6. LSR pain with inadequate response to conservative care (non-operative); participants must have tried at least one anti-inflammatory or analgesic medication (for at least 2 weeks at adequate doses) and at least one of the following: Physical therapy, bed rest, chiropractic manipulations, home directed lumbar and/or exercise programs. 7. Lumbar spine MRI images are available after the onset of clinical symptoms and correlate with localization of clinical symptoms. CT is acceptable for patients with contraindication for MRI. 8. Is independent, ambulatory, and can comply with post-treatment evaluations and visits. 9. Voluntary signature of the IRB approved Informed Consent Exclusion Criteria: 1. Untreated underlying psychological conditions (e.g. depression, chronic pain syndrome, etc.) as a contributor of pain 2. Bleeding disorders 3. Currently taking anticoagulant or immunosuppressive medication 4. Evidence on MRI or CT of recent vertebral fracture or segmental instability (spondylolisthesis) 5. Inflammatory or auto-immune based pathology (e.g. rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, polymyalgia, polymyositis, gout, pseudogout, etc.) 6. Co-existing hip or knee pain localized to the joint structures that may interfere with the participant's ability to participate in the study or interfere with pain assessments 7. Any central canal stenosis with neurogenic claudication (not including foraminal stenosis) with pain present mostly during walking and signs of lumbar stenosis on lumbar spine MRI/CT 8. Has undergone a surgical procedure for back pain (e.g. discectomy, artificial disc replacement, fusion, etc) 9. Presence of spinal cord stimulator 10. Received epidural steroid injection or nerve blocks within the last 2 months 11. Use of chronic opioids 12. Documented history of drug abuse within the last 6 months 13. Use of immunosuppressants, oral or intravenous steroids in the last 3 months 14. Is pregnant 15. Allergy or intolerance to study medication (e.g. lidocaine, etc.) 16. Condition represents a worker's comp case and/or is involved in health-related litigation 17. Presence of clinically significant disease that may interfere with the evaluation of safety and other clinical outcomes in the study 18. Any other condition, that in the opinion of the investigator, would preclude the patient from enrollment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lumbar radiculopathy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centeno-Schultz Clinic
Broomfield, Colorado, 80021, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sling exercises rewire back pain? trial tests muscle control in sciatica
- Can contrast spread predict which sciatica injection works?
- Can a single injection quiet nerve pain from a pinched spine?
- Can a simple leg test pinpoint which nerve is compressed?
- Can a simple needle angle change how well steroid injections relieve sciatica?
- Can the right traction position ease sciatica?